Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Exploring Slc30a6 As a Potential Prognostic, Immunomodulatory, and Therapeutic Biomarker in Various Cancers With a Focus on Pancreatic Cancer: A Pan-Cancer Analysis Publisher



Maghool F1 ; Kadkhodaei Elyaderani P1 ; Mohammadzadeh S1 ; Hosseini A2 ; Heidari A3 ; Samadi P1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Poursina Hakim Digestive Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Medical Genetics, University of Tehran, Tehran, Iran
  3. 3. Department of Cell and Molecular Biology, Faculty of Biological Science and Technology, University of Isfahan, Isfahan, Iran

Source: Egyptian Journal of Medical Human Genetics Published:2024


Abstract

Background: Our study investigates the multifaceted role of the gene SLC30A6 across 33 distinct cancer types. Understanding the function and impact of SLC30A6 in cancer biology is crucial, as previous studies have hinted at its aberrant expression and potential involvement in tumor progression. This research aims to elucidate the expression patterns, methylation variations, mutational signatures, and survival implications of SLC30A6, along with its engagement with the immune system in various cancers and specially in pancreatic cancer. Methods: We conducted a comprehensive analysis of SLC30A6 using data from 33 different cancer types, and all data were analyzed in silico. The study involved examining expression levels, performing correlation analyses with clinical outcomes, assessing methylation variations, and identifying mutational signatures. Functional enrichment analyses were carried out to understand the gene's involvement in biological pathways. Additionally, we evaluated the relationship between SLC30A6 expression and immune cell infiltration levels to uncover its role in the tumor microenvironment. Results: SLC30A6 was found to be significantly up-regulated in the majority of the 33 cancer types analyzed. High expression levels of SLC30A6 were consistently correlated with poor survival outcomes, indicating its potential role in cancer prognosis. Functional enrichment analyses revealed that SLC30A6 is involved in key pathways related to tumor progression, including cell proliferation and apoptosis. Moreover, SLC30A6 showed significant associations with diverse immune pathways, suggesting its involvement in immune regulation. Notably, our analysis demonstrated a significant correlation between SLC30A6 expression and the infiltration levels of key immune cells, highlighting its dual immunosuppressive and immunostimulatory roles in a pan-cancer context. Moreover, SLC30A6 is significantly overexpression in pancreatic cancer and have shown different clinical associations as above. Conclusion: Our study provides comprehensive insights into the complex interplay between SLC30A6 and cancer development. These findings position SLC30A6 as a promising prognostic biomarker and therapeutic target across diverse cancer types, highlighting its importance in future cancer research and treatment strategies. © The Author(s) 2024.
Related Docs
View other Related Docs
1. A Pan-Cancer Analysis Indicates Long Noncoding Rna Hand2-As1 As a Potential Prognostic, Immunomodulatory and Therapeutic Biomarker in Various Cancers Including Colorectal Adenocarcinoma, Cancer Cell International (2023)
2. Identification of Genes With High Heterogeneity of Expression As a Predictor of Different Prognosis and Therapeutic Responses in Colorectal Cancer: A Challenge and a Strategy, Cancer Cell International (2022)
3. Analysis of a Four-Component Competing Endogenous Rna Network Reveals Potential Biomarkers in Gastric Cancer: An Integrated Systems Biology and Experimental Investigation, Advanced Biomedical Research (2023)
4. Steroid Receptor Rna Activator Gene Footprint in the Progression and Drug Resistance of Colorectal Cancer Through Oxidative Phosphorylation Pathway, Life Sciences (2021)
5. Altered Expression of Linc-Ror in Cancer Cell Lines and Tissues, Tumor Biology (2016)
6. Assessment of Immuno-Histochemical Expression of Mbd1 in Colorectal Adenocarcinoma and Its Correlations With Prognostic Factors, Middle East Journal of Digestive Diseases (2020)
7. Identification of Syt10 As a Potential Prognostic Biomarker in Esophageal Cancer by Comprehensive Analysis of a Mrna-Pseudogene/Lncrna-Mirna Cerna Network, Human Gene (2023)
8. Differential Expression and Pathological Implications of Linc01089 and Linc01578 in Acute Myeloid Leukemia, Gene Reports (2025)
Experts (# of related papers)
View all Related Experts
Parvaneh Nikpour (8)
Marzieh Rezaei (2)
Other Related Docs
9. An Effective Concentration of 5-Aza-Cdr to Induce Cell Death and Apoptosis in Human Pancreatic Cancer Cell Line Through Reactivating Rassf1a and Up-Regulation of Bax Genes, Iranian Journal of Medical Sciences (2018)
10. Dna-Methyltransferase 3B 39179 G > T Polymorphism and Risk of Sporadic Colorectal Cancer in a Subset of Iranian Population, Journal of Research in Medical Sciences (2011)
11. Augmented Expression Levels of Lncrnas Eccebpa and Uca1 in Gastric Cancer Tissues and Their Clinical Significance, Iranian Journal of Basic Medical Sciences (2017)
12. Expression Analysis of Hif-3Α As a Potent Prognostic Biomarker in Various Types of Human Cancers: A Case of Meta-Analysis, Research in Pharmaceutical Sciences (2022)
13. Exploring the Role of Interleukin 11 in Cancer Progression, Patient Survival, and Therapeutic Insights, Molecular Biology Reports (2024)
14. Clinicopathological Significance and Prognostic Role of Lag3 + Tumor-Infiltrating Lymphocytes in Colorectal Cancer; Relationship With Sidedness, Cancer Cell International (2023)
15. A Bioinformatics Approach of Specificity Protein Transcription Factors in Head and Neck Squamous Cell Carcinoma, Research in Pharmaceutical Sciences (2024)
16. Screening and Identification of Potential Biomarkers for Pancreatic Cancer: An Integrated Bioinformatics Analysis, Pathology Research and Practice (2023)
17. Integrative Analysis of Dna Methylation and Gene Expression Through Machine Learning Identifies Stomach Cancer Diagnostic and Prognostic Biomarkers, Journal of Cellular and Molecular Medicine (2023)
18. Clear Cell Renal Cell Carcinoma: A Comprehensive in Silico Study in Searching for Therapeutic Targets, Kidney and Blood Pressure Research (2023)
19. Identification of Cancer/Testis Antigens Related to Gastric Cancer Prognosis Based on Co-Expression Network and Integrated Transcriptome Analyses, Advanced Biomedical Research (2023)
20. Tim3 and Pd-1 As a Therapeutic and Prognostic Targets in Colorectal Cancer: Relationship With Sidedness, Clinicopathological Parameters, and Survival, Frontiers in Oncology (2023)
21. Construction of a Three-Component Regulatory Network of Transcribed Ultraconserved Regions for the Identification of Prognostic Biomarkers in Gastric Cancer, Journal of Cellular Biochemistry (2023)
22. In-Silico Identification of Therapeutic Targets in Pancreatic Ductal Adenocarcinoma Using Wgcna and Trader, Scientific Reports (2024)
23. Integrative Bioinformatics Analysis of Acs Enzymes As Candidate Prognostic and Diagnostic Biomarkers in Colon Adenocarcinoma, Research in Pharmaceutical Sciences (2023)
24. The Stromelysin-1 5A/5A Genotype Enhances Colorectal Cancer Cell Invasion in Iranian Population, Journal of Research in Medical Sciences (2012)
25. Novel Biomarkers for Neoplastic Progression From Ulcerative Colitis to Colorectal Cancer: A Systems Biology Approach, Scientific Reports (2023)
26. Analysing Glycolysis-Related Genes Reveals the Prognostic and Diagnostic Relevance of Ier3 and Agrn in Colorectal Cancer, Genes and Genomics (2025)
27. Investigating Combined Hypoxia and Stemness Indices for Prognostic Transcripts in Gastric Cancer: Machine Learning and Network Analysis Approaches, Biochemistry and Biophysics Reports (2025)